The Role of Inflammation in Treatment-Resistant Depression


Works Cited

  1. Annamaria Cattaneo, Clarissa Ferrari, Rudolf Uher, Luisella Bocchio-Chiavetto, Marco Andrea Riva, the MRC ImmunoPsychiatry Consortium, Carmine M. Pariante, Absolute Measurements of Macrophage Migration Inhibitory Factor and Interleukin-1-? mRNA Levels Accurately Predict Treatment Response in Depressed Patients, International Journal of Neuropsychopharmacology, Volume 19, Issue 10, October 2016, pyw045,
  2. Capuron, L., et al. “Association between decreased serum tryptophan
    concentrations and depressive symptoms in cancer patients undergoing
    cytokine therapy.” Molecular Psychiatry, vol. 7, 18 June 2002, pp. 468-72,
    doi:10.1038/ Accessed 19 July 2019.
  3. Capuron, Lucile, et al. “Treatment of cytokine-induced depression Author links open overlay panel.” Brain, Behavior, and Immunity, vol. 16, no. 5, Oct. 2002, pp. 575-80, doi:10.1016/S0889-1591(02)00007-7.
  4. Capuron L, Raison CL, Musselman DL, et al: “Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy”. Am J Psychiatry, vol. 160, 2003, pp. 1342-1345. Doi: 10.1176/appi.ajp.160.7.1342. Accessed 18 July 2019.
  5. Dantzer, Robert, et al. “Inflammation-associated depression: From serotonin to kynurenine.” Psychoneuroendocrinology, vol. 36, no. 3, pp. 426-36, doi:10.1016/j.psyneuen.2010.09.012. Accessed 19 July 2019.
  6. Fourrier, C., Sampson, E., Mills, N.T. et al. Trials (2018) 19: 447. doi: 10.1186/s13063-018-2829-7
  7. Harmer, Catherine J., et al. “How do antidepressants work? New perspectives for refining future treatment approaches.” Lancet Psychiatry, 31 January 2017,pp. 409-18, doi:10.1016/S2215-0366(17)30015-9. Accessed 19 July 2019.
  1. Hugo Juárez Olguín, David Calderón Guzmán, Ernestina Hernández García, and Gerardo Barragán Mejía, “The Role of Dopamine and Its Dysfunction as a Consequence of Oxidative Stress,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 9730467, 13 pages, 2016.
  2. Jiang, Haiteng, et al. “Hyperactive frontlimbic and frontocentral
    resting-state gamma connectivity in major depressive disorder.” National
    Center for Biotechnology Information, vol. 257, 2 July 2019, doi:10.1016/
    j.jad.2019.06.066. Accessed 19 July 2019. Abstract.
  3. Kiecolt-Glaser, Janice K et al. “Inflammation: depression fans the flames and feasts on the heat.” The American journal of psychiatry vol. 172,11 (2015): 1075-91. doi:10.1176/appi.ajp.2015.15020152
  4. Marieke Wichers, Michael Maes. “The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans”. International Journal of Neuropsychopharmacology. vol. 5, no. 4, December 2002, pp. 375–388. doi: 10.1017/S1461145702003103. Accessed 18 July 2019.
  5. Maydych, Viktoriya. “The Interplay Between Stress, Inflammation, and Emotional Attention: Relevance for Depression.” Frontiers in Neuroscience, 24 Apr.2019, doi:10.3389/fnins.2019.00384. Accessed 18 July 2019.
  6. Mechawar, N., and J. Savitz. “Neuropathology of mood disorders: do we see the stigmata of inflammation?” Translational Psychiatry, doi:10.1038/
    tp.2016.212. Accessed 19 July 2019.
  7. Miller, Andrew H., and Charles L. Raison. “The role of inflammation in
    depression: from evolutionary imperative to modern treatment target.”
    Nature Review Immunology, 29 Dec. 2015, doi:10.1038/nri.2015.5. Accessed 18 July 2019.
  8. Muller, N., et al. “The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine.” Molecular Psychiatry, vol.11, 21 Feb. 2006, pp. 680-84, doi:10.1038/ Accessed 19 July 2019.
  1. Newcomer, J W et al. “NMDA receptor function, memory, and brain aging.” Dialogues in clinical neuroscience vol. 2,3 (2000): 219-32. Accessed 18 July 2019.
  2. Palazidou, Eleni. “The neurobiology of depression.” British Medical Bulletin, vol. 101, no. 1, Mar. 2012, pp. 127-45, doi:10.1093/bmb/lds004. Accessed 19 July 2019.
  3. Regan, T, Gill, AC, Clohisey, SM, et al. “Effects of anti?inflammatory drugs on the expression of tryptophan?metabolism genes by human macrophages”. J Leukoc Biol. 2018; 103: 681– 692. doi: 10.1002/JLB.3A0617-261R. Accessed 18 July 2019.
  4. Ruhe, H. G., et al. “Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies.”Molecular Psychiatry, vol. 12, pp. 331-59, doi:10.1038/ Accessed 19 July 2019.
  5. Smith, R. S. “The macrophage theory of depression.” Medical Hypotheses, vol. 35, no. 4, Aug. 1991, doi:10.1016/0306-9877(91)90272-Z.


Comments are closed.